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Inter-individual variability in memory performance has been suggested to result, in part,
from genetic differences in the coding of proteins involved in long-term potentiation (LTP).
The present study examined the effect of a single-nucleotide polymorphism (SNP) in the
KIBRA gene (rs17070145) on episodic memory performance, using multiple measures
of verbal and visual episodic memory. A total of 256 female and 130 male healthy,
older adults (mean age = 60.86 years) were recruited from the Tasmanian Healthy
Brain Project (THBP), undergoing both neuropsychological and genetic testing. The
current study showed no significant effect of the KIBRA polymorphism on performance
on the Rey Auditory Verbal Learning Task, Logical Memory test, Paired Associates
Learning test or Rey Complex Figure Task. The results suggest there is little to no
functional significance of KIBRA genotype on episodic memory performance, regardless
of modality.
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INTRODUCTION
The term “memory” encapsulates different systems that can be
differentiated by the type of information processed. Declarative
memory, one of two major distinctions of memory, involves the
conscious recollection about facts (semantic memory) and events
(episodic memory; Squire, 2004). Decline in memory perfor-
mance, particularly episodic memory, is a major characteristic of
dementia, particularly in early-middle stages. However, it is also
well established that there is normal aging-associated decline of
episodic memory in the absence of dementia (Mormino et al.,
2009). Therefore, with aging populations, it is not only impor-
tant to investigate strategies to delay dementia onset, but also
to increase resistance to aging-related cognitive decline. As the
heritability estimate of memory ability is approximately 50%
(McClearn et al., 1997), genetic components have been investi-
gated to determine whether they have either a protective effect
on, or predict a faster decline of, normal aging-associated cog-
nitive decline. The association of genes such as brain-derived
neurotrophic factor (BDNF) and apolipoprotein-E (ApoE) with
cognitive decline and late-onset Alzheimer’s disease (AD) has
been investigated (e.g., Corder et al., 1993; Slooter et al., 1998;
Hariri et al., 2003; Cosentino et al., 2008). Such insight assists in
informing the development of strategies to increase resistance to
memory decline in older adults.
It has been proposed that the KIBRA gene (also known
as WWC1) may also play a role in human memory
(Papassotiropoulos et al., 2006), potentially accounting for
some of the individual variability in memory decline. The
KIBRA single-nucleotide polymorphism (SNP) (rs17070145) was
originally identified in a genome-wide association study (GWAS),
as it met criteria of being associated with memory performance
(Papassotiropoulos et al., 2006). Follow-up studies demonstrated
that the C→ T substitution within the ninth intron of the KIBRA
gene was significantly associated with greater episodic memory
performance (Papassotiropoulos et al., 2006). Further, there was
no significant relationship between genotype and performance on
attention, concentration and working memory tasks, suggesting
that KIBRA has a specific association with episodic memory.
Additionally, this study also demonstrated that T-allele carriers
had significantly better visual episodic memory performance
than non-carriers, suggesting the effect of KIBRA genotype is
independent of stimulus modality.
The KIBRA gene has been shown to encode KIBRA pro-
tein, which is expressed in brain regions related to mem-
ory, including the hippocampus and temporal lobe in humans
(Papassotiropoulos et al., 2006). Animal studies provide prelim-
inary evidence that the gene and associated protein are implicated
in cellular processes underlying memory and, thus, are related to
memory performance. This is illustrated by adult KIBRA knock-
out mice demonstrating significant deficits in learning and mem-
ory, specifically in long-term potentiation (LTP) and long-term
depression in the hippocampus (Makuch et al., 2011). Long-term
potentiation has been proposed to underlie memory formation,
involving the activation of proteins, gene expression, protein
synthesis and the development of synaptic connections (Lynch,
2004). There is evidence to suggest that KIBRA may be involved
in LTP, as KIBRA protein interacts with proteins that play a role in
altering synaptic plasticity for memory formation, such as protein
kinase M zeta, dendrin and synaptopodin (Kremerskothen et al.,
2003; Schneider et al., 2010).
Multiple investigations have subsequently investigated the
association between KIBRA T-allele and superior verbal episodic
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memory performance. While many studies provide further sup-
port for this association (Almeida et al., 2008; Schaper et al., 2008;
Bates et al., 2009; Preuschhof et al., 2010; Kauppi et al., 2011;
Wang et al., 2013), some report no association between KIBRA
genotype and verbal episodic memory performance (Need et al.,
2008; Burgess et al., 2011; Wersching et al., 2011; Laukka et al.,
2013; see Schneider et al., 2010 for a review). In addition to this,
the KIBRA T-allele has also been reported to have a deleterious
effect, whereby T-allele carriers have worse performance on verbal
episodic memory tests (Nacmias et al., 2008). Despite this, the
majority of results from studies investigating the effect of KIBRA
genotype are consistent with the original findings. Further, studies
utilizing relatively small samples (e.g., Schaper et al., 2008) still
demonstrate an effect of KIBRA on episodic memory perfor-
mance (Rey Auditory Learning Verbal Learning Test, RAVLT),
suggesting that the effect of KIBRA on episodic memory may be
of a sufficient magnitude to be detected within smaller samples.
The aim of the present study was to clarify the effect of KIBRA
polymorphism on episodic memory performance of healthy aging
individuals, using multiple measures of both verbal and visual
episodic memory, and by examining immediate and delayed
recall.
MATERIALS AND METHODS
PARTICIPANTS
The sample in the present study consisted of 386 participants
who were drawn from the Tasmanian Healthy Brain Project
(THBP), a world-first, large-scale longitudinal study investigating
the protective effect of later-life education on age-related cognitive
decline in people aged between 50 and 79 years (Summers et al.,
2013). The sample consisted of 256 females and 130 males, with
a combined mean age of 60.86 (SD = 6.79). Participants were
excluded from the THBP if they had a history of medical, psycho-
logical or psychiatric conditions independently associated with
impairments to cognitive function (see Summers et al., 2013). All
participants provided informed consent prior to commencing the
study and ethics approval was obtained from the Tasmanian Social
Sciences Human Research Ethic Committee (H11070).
GENOTYPING
Oragene DNA Self-Collection Kits (DNA Genotex, Ottawa,
Canada) were used to collect saliva samples for DNA extraction,
which was carried out using standard methods. KIBRA poly-
morphism was determined using restriction polymerase chain
reaction-fragment length polymorphism (PCR-RFLP) analysis.
Similarly to Wersching et al. (2011), two primers were used to
select a 198 basepair (bp) fragment containing the polymor-
phic site rs17070145 (forward: atcctcttgaggcttcactgg, backward:
actttcaacacaatgaacaagg). The total volume of amplification reac-
tions was 12 µl, consisting of 1 µl of DNA, 0.6 µl of each primer,
6µl of MyTaq DNA polymerase and 3.8µl of DEPC treated water.
Following the PCR program, the products were then digested in
5 U of MseI restriction enzyme for 16 h at 37◦C. As there is no
MseI site in the C-allele, but this is present in the T-allele, the PCR
product was cut into two fragments of 128 and 70 bp in length
only when the T-allele was present. Therefore, a single band at
198 bp indicated a CC genotype, whereas a band at both 128 bp
and 70 bp indicated a TT genotype. Bands at all three bp locations
indicated a CT genotype. Polymerase chain reaction products
were then viewed using 3.5% agarose gels stained with Sybr-safe
to allow visualization of DNA. All samples were genotyped twice
to ensure accuracy, with 87.3% of samples in concordance. In the
instance of conflicting results, the triplicate result was taken.
NEUROPSYCHOLOGICAL TESTING
As part of the THBP, participants underwent annual cognitive
assessment requiring participants to complete a standardized
battery of neuropsychological measures selected to assess core
cognitive function. A qualified examiner administrated the tests
in an individual assessment session as part of standard protocol
of the THBP (described by Summers et al., 2013). The cognitive
measures analyzed in the current study formed a part of the
larger cognitive battery. Verbal episodic memory performance was
assessed using the RAVLT and the Logical Memory Test (LM; a
subtest from the Wechsler Memory Scale—Third Edition; WMS-
III). Visual episodic memory performance was assessed using the
Rey Complex Figure Test (RCFT) and the Paired Associates Learn-
ing Task (PAL; a test from the Cambridge Neuropsychological Test
Assessment Battery, CANTAB).
The RAVLT (Strauss et al., 2006) is a serial word list-learning
task in which 15 words are presented across five trials (list A),
with recall assessed after each trial. Recall for an interference list
of 15 words is then assessed (list B), followed by delayed recall
of the initial list of 15 words (list A recall). The LM test (Strauss
et al., 2006) assesses a participant’s capacity to recall two prose
passages immediately after presentation and again following a
30-min delay.
The RCFT (Strauss et al., 2006) assesses participants’ capacity
to recall a complex geometric design. The participant was shown
a standardized design, which they were asked to reproduce as
best as possible while it remained visible to them. Following this,
both the stimulus figure and the participant’s copy were removed
from view. After a delay of 20–30 min, the participant redrew the
design from memory, without prior warning that they would be
required to do so. The design was scored based on the accurate
placement and reproduction of 18 specific design elements, with
higher scores indicating greater performance.
The PAL test (Cambridge Cognition Ltd., 2004) was conducted
on a touch-screen computer that displayed six boxes opening in
a random order. One or more boxes contained a pattern, which
at the end of all the boxes opening, were displayed individually
in the middle of the screen. Participants then had to touch the
box where the pattern was originally located. If an error was
made, the patterns were re-presented to remind the participant
of the location. Throughout the test, the difficulty increased by
increasing the number of patterns presented.
These memory tests have established high levels of reliability
and validity and have been used extensively to assess episodic
memory in age-related cognitive decline, mild cognitive impair-
ment and dementia (Strauss et al., 2006).
ANALYSIS
Differences in episodic memory performance were compared
across the three KIBRA genotype groups: homozygous CC,
Frontiers in Aging Neuroscience www.frontiersin.org October 2014 | Volume 6 | Article 270 | 2
Franks et al. KIBRA polymorphism and memory
homozygous TT and heterozygous CT. The three groups were
dummy coded prior to analyses (0 = CC, 1 = CT, 2 = TT). The CT
and TT genotypes were also combined for further analysis with
respect to the CC group, to examine the effect of inheritance of
any T variant.
Raw scores from the four tests of episodic memory were used
for the analyses, as the correlations between age and raw scores
were small (r = <0.3), suggesting that z-score transformations
were not required. One-way ANOVAs were used to compare the
mean scores on the RAVLT, LM test, PAL test and RCFT across
the three groups. Assumptions of homogeneity of variance were
assessed using Levene’s test and were met unless explicitly stated.
Further, two 3 (Genotype: CC, CT, TT) × 5 (Trial: 1, 2, 3, 4, 5)
mixed ANOVAs were conducted to assess the effect that genotype
has on learning in order to determine whether an earlier stage of
memory may be susceptible to genotype effects. Violations of the
assumption of sphericity were adjusted using Greenhouse-Geisser
corrections.
In addition, linear hierarchical regression analyses were con-
ducted to determine whether the demographic variables of age,
intelligence, previous education and gender mask the effect of
genotype on episodic memory performance. This allowed the
variance of such variables to be partialled out, demonstrating the
underlying relationship between genotype and episodic memory
performance.
Analyses were performed using IBM SPSS version 21.0.
RESULTS
Genetic analysis demonstrated that 176 participants were geno-
typed as CC carriers, 180 as CT carriers and 30 as TT carriers
of the KIBRA gene. The observed genotype distribution was not
significantly different from the frequency distribution previously
observed in an Australian sample (Almeida et al., 2008; χ2 (2,
N = 386) = 2.04, p = 0.361), suggesting that the sample used
in the present study is in Hardy-Weinburg equilibrium. There
were no significant differences between the three genotype groups
in regards to age, sex, years of previous education, premorbid
intellectual capacity (Wechsler Test of Adult Reading) or current
intellectual capacity (Wechsler Adult Intelligence Scale-III-SF1;
see Table 1).
VERBAL EPISODIC MEMORY PERFORMANCE
Performance on the RAVLT and the LM test was assessed
using three measures from each test. Rey Auditory Learning
Verbal Learning Test performance was assessed by the total
number of words recalled from all trials, mean number of
words recalled from list A and mean number of words recog-
nized from list A. Performance on the LM test was assessed
by scores of immediate recall from the first story, delayed
recall from the second story and mean percent retention from
the second story. No significant differences between KIBRA
genotype groups on any measure of verbal episodic mem-
ory performance were present (p > 0.05; see Table 2). There
was no statistical difference between T and non-T carriers in
performance.
Analysis of learning over trials on the RAVLT (Figure 1)
demonstrated there was no significant interaction between trial
number and KIBRA genotype on mean number of words recalled
(F (6.60,1263.45) = 0.62, p = 0.732, ηp2 = 0.003), following a
Greenhouse-Geisser correction (ε = 0.83), see Figure 1. The
ANOVA did show a significant main effect of trial (F (3.30,1263.45) =
680.24, p < 0.001, ηp2 = 0.640), following a Greenhouse-Geisser
correction, but the main effect of genotype was not significant
(F (2,383) = 1.01, p = 0.360, ηp2 = 0.005).
Table 1 | Difference between KIBRA genotype groups on demographic variables.
CC (n = 176) CT (n = 180) TT (n = 30)
Measure M (SD) M (SD) M (SD) p
Age–years 60.27 (6.62) 61.34 (7.14) 61.37 (5.44) 0.302
Sex ratio (males:females) 59:117 66:114 5:25 0.100
Prior years of education 14.11 (2.84) 13.81 (2.58) 13.78 (2.95) 0.548
WTAR estimated FSIQ 112.84 (5.15) 111.87 (10.10) 113.17 (6.24) 0.846
WAIS-III-SF1 FSIQ 120.15 (13.37) 119.34 (12.95) 119.77 (12.65) 0.445
Note: WTAR = Wechsler Test of Adult Reading, FSIQ = full scale intelligence quotient, WAIS-III-SF1 = Wechsler Adult Intelligence Scale 3rd edition Short Form 1.
Table 2 | Verbal episodic memory performance across KIBRA genotype.
CC (n = 176) CT (n = 180) TT (n = 30)
Measure M (SD) M (SD) M (SD) p
RAVLT Total recall 53.06 (9.09) 52.18 (9.00) 54.67 (7.22) 0.315
RAVLT List A recall 11.15 (2.72) 10.90 (2.80) 11.83 (2.14) 0.201
RAVLT List A recognition 13.49 (1.80) 13.28 (1.94) 13.67 (1.35) 0.405
LMI immediate recall 48.18 (8.28) 48.21 (7.96) 49.77 (6.23) 0.585
LMII delayed recall 30.05 (6.53) 30.06 (6.21) 31.03 (5.95) 0.719
LMII percent retention 87.45 (11.23) 86.85 (10.99) 87.94 (8.93) 0.819
Note: RAVLT = Rey Auditory Verbal Learning Task, LM = Logical Memory Test.
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FIGURE 1 | Mean number of words recalled on each trial of the RAVLT
across KIBRA genotype, showing no significant interaction. Error bars
display 95% confidence intervals.
VISUAL EPISODIC MEMORY PERFORMANCE
Performance on the PAL test and the RCFT was assessed using
three and two measures of memory performance, respectively.
Paired Associates Learning Task test performance was assessed
using mean adjusted total errors, mean trials to success and
mean total errors when six shapes were presented. Performance
on the RCFT was assessed using mean recall and percent reten-
tion (the ratio of what the participant recalled relative to what
they copied). No significant differences between KIBRA genotype
groups existed on any measure of visual episodic memory perfor-
mance (p> 0.05; see Table 3). In addition, there was no statistical
difference between T and non-T carriers in performance.
Analysis of learning over trials on the PAL test (Figure 2)
demonstrated that there was no significant interaction between
trial number and KIBRA genotype on mean number of errors
made (F (2.88,551.44) = 0.35, p = 0.784, ηp2 = 0.002), following
a Greenhouse-Geisser correction (ε = 0.36), see Figure 2. The
ANOVA did show a significant main effect of trial (F (1.44,551.44) =
128.24, p < 0.001, ηp2 = 0.251), following a Greenhouse-Geisser
FIGURE 2 | Mean number of total errors made across trials on the PAL
test, showing no significant interaction between KIBRA genotype.
Error bars display 95% confidence intervals.
correction, but the main effect of genotype was not significant
(F (2,383) = 0.01, p = 0.988, ηp2 < 0.001).
HIERARCHICAL LINEAR REGRESSION
Hierarchical linear regression analyses were used to determine
the underlying relationship between KIBRA genotype and
episodic memory performance after the variance attributed
by known demographic variables of age, gender, prior
education, WTAR estimated IQ, and WAIS-III-SF1 FSIQ
had been partialled out. The analyses demonstrated that
KIBRA genotype, entered in the second step, resulted in a
non-significant change in the amount of variance explained
above that of the demographic variables for all measures
of both verbal and visual episodic memory performance
(p> 0.05).
DISCUSSION
This study sought to examine the effect of KIBRA polymorphism,
particularly specific genotypes, on verbal and visual episodic
Table 3 | Visual episodic memory performance across KIBRA genotype.
CC (n = 176) CT (n = 180) TT (n = 30)
Measure M (SD) M (SD) M (SD) p
PAL Total errors adjusted 18.49 (19.86) 18.63 (19.43) 18.03 (22.23) 0.988
PAL Mean trials to success 1.72 (0.53) 1.72 (0.49) 1.65 (0.42) 0.761
PAL Total errors 6 shapes 6.30 (7.60) 5.69 (7.00) 5.57 (9.41) 0.751
RCFT Recall 21.87 (6.03) 22.11 (6.38) 21.70 (5.53) 0.908
RCFT Percent retention 61.79 (16.58) 62.26 (17.34) 61.40 (15.00) 0.948
Note: PAL = Paired Associates Learning Test, RCFT = Rey Complex Figure Task.
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memory performance of healthy aging individuals. The CC geno-
type of the KIBRA was not associated with significantly lower
performance on the RAVLT, the LM test, the PAL test and the
RCFT compared to those with CT or TT genotypes. The results
provide no evidence of a gene-dose relationship present for the
T-allele, as there was no advantage to heterozygous T-allele car-
riers (CT genotype) over non T-allele carriers (CC genotype).
These findings suggest that KIBRA polymorphism has little to
no influence on either verbal or visual episodic memory per-
formance. The present study incorporated multiple measures
of both verbal and visual episodic memory to ensure reliable
assessment and to examine different components of memory,
such as immediate and delayed recall. As there was no effect
of KIBRA polymorphism on either delayed or immediate recall
across all tests of episodic memory, this suggests that the indi-
vidual polymorphism effect does not selectively influence only
one component of memory. Further, analyses of the PAL test
and the RCFT learning curves suggest that KIBRA polymorphism
does not have an effect on the rate of acquisition of information
(learning), indicating that KIBRA polymorphism does not affect
an earlier stage of memory. In addition, the linear hierarchical
regression analyses demonstrated no significant contribution of
KIBRA polymorphism to the variance explained in verbal or
visual episodic memory performance, despite suggestions that the
effect of KIBRA polymorphism might be masked by other factors
(Burgess et al., 2011).
The finding that KIBRA polymorphism does not affect verbal
episodic memory performance clearly contradicts the findings of
the Papassotiropoulos et al. (2006) study, which demonstrated
differential performance between T-allele and non T-allele car-
riers. Differences between the genotype groups on delayed, but
not immediate recall, was also not supported by the present
study. This may be a result of delayed free recall being dependent
on a large-scale memory network, rather than one specific area
related to memory (Dickerson and Eichenbaum, 2010). There-
fore, the delayed free recall test may be relatively non-specific
and involve other brain areas where the KIBRA protein is not as
highly expressed and other proteins may exert some influence on
episodic memory performance.
The finding that the KIBRA polymorphism does not affect
visual episodic memory performance also contrasts with the
results from the original study showing a significant difference
between T-allele carriers and non-carriers (Papassotiropoulos
et al., 2006). However, it does provide support for the results
of Vassos et al. (2010) and Yasuda et al. (2010), which both
demonstrated that KIBRA polymorphism does not significantly
affect visual episodic memory performance. A standardized test
of visual episodic memory was not used in the Papassotiropoulos
et al. (2006) study and was the only study reporting an effect on
visual episodic memory, perhaps as the test may have assessed
more than just visual episodic memory ability.
It has been suggested that discrepancies in, or failure to
replicate findings in genetic research may be due to false positives
originally being reported as true (Kathiresan et al., 2004).
For example, although Schaper et al. (2008) supported the
original findings of Papassotiropoulos et al. (2006), the small to
medium Cohen’s d effect sizes reported (0.48 and 0.74) suggest
Table 4 | Comparison of the sample features in the present study to
other studies.
Study Years of prior education Full scale IQ
Schaper et al. (2008) 14.1–15.1 122.4–123.7 (VIQ)
Preuschhof et al. (2010) 12.4–13.3 N/A
Yasuda et al. (2010) 15.5–15.7 108.8
Current study 13.78–14.11 119.75
Note: N/A = not available, VIQ = verbal intelligence quotient.
approximately 57% to 67% overlap between the groups on scores
of episodic memory performance (Zakzanis, 2001), which may
not be functionally significant. Further, the Papassotiropoulos
et al. (2006) study reported the significant difference between
groups on delayed memory as only a difference of roughly 1.2
words, indicating a small effect size on performance. This is fur-
ther supported by a meta-analysis demonstrating that the KIBRA
polymorphism potentially explains only 0.5% of the variance in
episodic memory performance (Milnik et al., 2012). Hence, very
large sample sizes may be required to uncover such minor effect
size linkages between the KIBRA polymorphism and memory
performance. In this regard, it may be possible that KIBRA gene
variations may combine with other brain gene polymorphisms
(e.g., CLSTN2, Preuschhof et al., 2010, but not seen in Sédille-
Mostafaie et al., 2012; Laukka et al., 2013) to influence memory
performance, albeit effect sizes are likely to remain small.
With respect to potential limitations of the current study, as
the THBP is a longitudinal study that invites older individuals to
attend university to increase their education, this may introduce
some bias in the recruitment of participants. For example, only
motivated individuals or those who completed secondary school
or have previous university experience may be willing to partici-
pate, which would explain the above average levels of intelligence
and premorbid IQ seen in the current sample. Consequently, this
may impact on any generalizability of findings to different popu-
lations. However, the THBP sample features did not substantially
differ from the previous KIBRA studies that reported prior years
of education and intelligence scores (see Table 4).
The present study has extended the findings of previous
research investigating the KIBRA gene, particularly through the
analysis of the genotypes rather than the combined alleles, as well
as using multiple measures of episodic memory performance. The
results showed no influence of KIBRA genotypes on visual and
verbal episodic memory performance in healthy older adults.
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